Literature DB >> 2882227

Haloperidol metabolism and antipsychotic effect in schizophrenia.

A C Altamura, M C Mauri, R Cavallaro, A Gorni.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 2882227     DOI： 10.1016/s0140-6736(87)92848-0

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  7 in total

1.  Plasma concentrations of haloperidol are related to CYP2D6 genotype at low, but not high doses of haloperidol in Korean schizophrenic patients.

Authors:  H K Roh; J Y Chung; D Y Oh; C S Park; J O Svensson; M L Dahl; L Bertilsson
Journal:  Br J Clin Pharmacol       Date:  2001-09       Impact factor: 4.335

2.  Reduced haloperidol plasma concentration and clinical response in acute exacerbations of schizophrenia.

Authors:  M W Kelly; P J Perry; W H Coryell; D D Miller; S V Arndt
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

3.  Interconversion between haloperidol and reduced haloperidol in healthy volunteers.

Authors:  B S Chakraborty; J W Hubbard; E M Hawes; G McKay; J K Cooper; T Gurnsey; E D Korchinski; K K Midha
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

4.  Biliary excretion of reduced haloperidol glucuronide.

Authors:  N D Eddington; D Young
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

5.  Effect of quinidine on the interconversion kinetics between haloperidol and reduced haloperidol in humans: implications for the involvement of cytochrome P450IID6.

Authors:  D Young; K K Midha; M J Fossler; E M Hawes; J W Hubbard; G McKay; E D Korchinski
Journal:  Eur J Clin Pharmacol       Date:  1993       Impact factor: 2.953

Review 6.  Impact of clinical pharmacokinetics on neuroleptic therapy in patients with schizophrenia.

Authors:  K K Midha; J W Hubbard; S R Marder; B D Marshall; T Van Putten
Journal:  J Psychiatry Neurosci       Date:  1994-07       Impact factor: 6.186

7.  The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history.

Authors:  H Matsuno; T Uematsu; M Nakashima
Journal:  Br J Clin Pharmacol       Date:  1990-02       Impact factor: 4.335
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.